Proteonomix Inc.

Proteonomix Inc.
Stock Exchange Other OTC
EPS
-
Market Cap
$276.89 K
Shares Outstanding
7.91 M
Public Float
6.54 M

Profile

Address
140 East Ridgewood Avenue
Paramus New Jersey 07652
United States
Employees -
Website mailto:[email protected]
Updated 07/08/2019
Proteonomix, Inc. is a biotechnology company which engages in the discovery and development of stem cell therapeutic and cosmeceutical products. It develops pre clinical-stage therapeutic agents and treatments for diabetes, heart, and lung diseases. Proteonomix was founded by Michael Moshe Cohen on June 26, 1995 and is headquartered in Hawthorne, NJ.

Financials

View All

Michael Moshe Cohen
Chairman, President, CEO, COO, CAO & Controller
Steven Mark Byle
Director & Chief Technology Officer